FDA approves new drug for inhaled anthrax

Published



WASHINGTON (AP) — Federal health officials say they approved a new injectable drug from Human Genome Sciences to treat inhalable anthrax.

The Food and Drug Administration says raxibacumab will provide an alternative to antibiotic drugs that are currently the standard treatment for anthrax infection.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.